share_log

Candel Therapeutics | 8-K: Candel Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

SEC ·  Nov 14 08:21
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more